Category Archives: "Partners"

Bayer receives FDA approval of myBETAappâ„¢ and BETACONNECT Navigatorâ„¢
WHIPPANY, N.J., May 30, 2017 – Bayer today announced that the U.S. Food and Drug Administration (FDA) has approved a supplemental [...]
CMSC 2017 Annual Meeting – Celgene’s investigational therapy Ozanimod safe, effective in treating RMS
Long-term treatment for up to 12o weeks, with the investigational drug Ozanimod (RPC-1063), found to be effective and safe in patients [...]
CMSC 2017 Annual Meeting – Rituxan-treated multiple sclerosis patients three times more likely to have improved brain scans
Multiple sclerosis patients who start Rituxan (rituximab) treatment are three times more likely to have unchanged or improved brain-scan [...]
CMSC 2017 Annual Meeting – review suggests certain multiple sclerosis patient groups may discontinue DMTs
Older patients with secondary progressive multiple sclerosis (SPMS) as well as older relapsing patients whose MS has been inactive after [...]
CMSC 2017 Annual Meeting – Tysabri improves mental outlook for patients with secondary progressive MS
Long-term therapy with Tysabri (natalizumab) significantly improved the mental state of people with secondary progressive multiple [...]
CMSC 2017 Annual Meeting – multiple sclerosis patients should contribute to outcome measure development, study argues
Patients must help develop new outcome measures of multiple sclerosis (MS), since they and healthcare providers may have differing [...]
CMSC 2017 Annual Meeting – single session of ball-throwing exercise improves balance control in multiple sclerosis
Patients with relapsing-remitting multiple sclerosis (RRMS) regain part of their balance control after a single training session of [...]
CMSC 2017 Annual Meeting – Genentech starts site to connect multiple sclerosis patients and caregivers with resources
Genentech has rolled out a website to connect multiple sclerosis (MS) patients and caregivers with resources that can help [...]
CMSC 2017 Annual Meeting – all about teamwork in multiple sclerosis
NEW ORLEANS — The Consortium of Multiple Sclerosis Centers (CMSC) annual meetings always aim to offer a multidisciplinary educational [...]
The hidden costs of multiple sclerosis
MS is sneaky. It is expert at evading detection and diagnosis, and often brings a host of invisible symptoms that may come and go at [...]
  • (201) 487-1050
  • 3 University Plz Dr Ste 116, Hackensack, NJ 07601
  • info@mscare.org

Upcoming Testing Periods

WINTER 2024 TESTING PERIOD

Application Deadline: December 6th, 2023

First Day of Testing: Saturday, January 6th, 2024

Last Day of Testing: Saturday, January 20th, 2024

SUMMER 2024 TESTING PERIOD

Application Deadline: May 1st, 2024

First Day of Testing: Saturday, June 1st, 2024

Last Day of Testing: Saturday, June 15th, 2024

Resources

Visit PTC to download a PDF version of the Handbook. Candidates can also apply online.

For more information:

Professional Testing Corporation http://www.ptcny.com/

  • 212-356-0660
  • 1350 Broadway, 17th Floor, New York, NY 10018

CMSC provides leadership in clinical research and education; develops vehicles to share information and knowledge among members; disseminates information to the health care community and to persons affected by MS.

Contact Us
Contact Us





I have a question about

First

Last




Feel Free To contact Us
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Nam molestie, tellus id pellen tesque feugiat, sem sem cursus orci, a placerat ante ante nec massa. consectetuer adipiscing elit.

+1-222-333-4444

New York, NY 10123 USA

Mon - Sat 9:00 AM